Christer Frode Aas

7PUBLICATIONS
9CO-AUTHORS
Behavioural epidemiologyToxicology (incl. clinical toxicology)Major global burdens of diseaseDisease surveillancePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2023
Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial.

Aaron Guanliang Lim, Christer Frode Aas, Ege Su Çağlar

|Jun 01, 2021
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).

Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold

|Feb 28, 2021
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway.

Christer Frode Aas, Jørn Henrik Vold, Rolf Gjestad

|Sep 05, 2020
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.

Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit

|Aug 28, 2020
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017.

Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit

|Aug 11, 2020
Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017.

Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit

Pageof 2

Frequent Collaborators

3 joint publications

Lars Thore Fadnes

2 joint publications

Jørn Henrik Vold

2 joint publications

Peter Vickerman

1 joint publications

Rafael Alexander Leiva